Urothelial Carcinoma

Latest News

Opdivo Gets FDA Nod as Adjuvant Therapy for Muscle-Invasive Urothelial Cancer
Opdivo Gets FDA Nod as Adjuvant Therapy for Muscle-Invasive Urothelial Cancer

September 2nd 2021

Tecentriq and Keytruda may also be eventually approved as adjuvant therapies.

FDA Denies Vicineum Approval for Non-Muscle Invasive Bladder Cancer
FDA Denies Vicineum Approval for Non-Muscle Invasive Bladder Cancer

September 1st 2021

Feasibility Study Shows Mobile Devices Help Patients Communicate Cancer Treatment Effects
Feasibility Study Shows Mobile Devices Help Patients Communicate Cancer Treatment Effects

August 31st 2021

3 Upcoming Urothelial Cancer Conferences
3 Upcoming Urothelial Cancer Conferences

August 12th 2021

Updated SITC Immunotherapy Guidelines for Urothelial Cancer
Updated SITC Immunotherapy Guidelines for Urothelial Cancer

August 3rd 2021

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.